Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Research

• Publication date

  1996-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8665496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro.

  1996cited by this paper
• Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.

  1996cited by this paper
• Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.

  1995cited by this paper
• 'Bystander killing' induces apoptosis and is inhibited by forskolin.

  1995cited by this paper
• Genetic delivery of enzymes for cancer therapy.

  1995cited by this paper
• Regulators of cell death.

  1995cited by this paper
• Effect of Herpes Simplex Virus Thymidine Kinase Expression Levels on Ganciclovir-Mediated Cytotoxicity and the “Bystander Effect”

  1995cited by this paper
• Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir.

  1995cited by this paper
• The “Bystander Effect”: Association of U-87 Cell Death with Ganciclovir-Mediated Apoptosis of Nearby Cells and Lack of Effect in Athymic Mice

  1995cited by this paper
• The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.

  1995cited by this paper
• Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.

  1995cited by this paper
• Metabolic suicide genes in gene therapy.

  1994cited by this paper
• Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

  1994cited by this paper
• Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.

  1994cited by this paper
• Bcl-2 overexpression abolishes early calcium waving preceding apoptosis in NIH-3T3 murine fibroblasts.

  1994influential reference
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

  1993influential reference
• Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays.

  1993cited by this paper
• Gene therapy of maliganant brain tumors: A rat glioma line bearing the herpes simplex virus type 1‐thymidine kinase gene and wild type retrovirus kills other tumor cells

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

  1986cited by this paper
• Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

  1986cited by this paper
• Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth‐inhibitory properties of (E)‐5‐(2‐bromovinyl)‐2'‐deoxyuridine and related compounds

  1985cited by this paper

• Application and progress of induced pluripotent stem in chronic wound healing: a narrative review

  2026cites this paper
• Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers

  2023cites this paper
• Engineering Human Pluripotent Stem Cell Lines to Evade Xenogeneic Transplantation Barriers

  2023cites this paper
• Effects of cancer-associated fibroblasts deletion using HSVtk suicide system in OSCC.

  2023cites this paper
• “Non-Essential” Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review

  2020cites this paper
• Doxorubicin Improves Cancer Cell Targeting by Filamentous Phage Gene Delivery Vectors

  2020cites this paper
• Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase

  2020cites this paper
• Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics

  2020cites this paper
• In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies

  2020cites this paper
• Investigating the evolvability of 'Escherichia coli nfsA' via simultaneous site-directed mutagenesis

  2019cites this paper
• Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial

  2019cites this paper
• Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma

  2019cites this paper
• Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets

  2019cites this paper
• Methioninase Gene Therapy.

  2019cites this paper
• A Cell-Specific Nuclear Factor-Kappa B–Activating Gene Expression Strategy for Delivering Cancer Immunotherapy

  2019cites this paper
• Presence of human herpes virus 1-thymidine kinase in testis of azoospermic infertile herpes-infected patients.

  2018cites this paper
• Genotype-Specific Insertion of Cytotoxic Genetic Elements Into Cancer Cells

  2018cites this paper
• Graphene oxide–hydroxyapatite nanocomposites effectively deliver HSV-TK suicide gene to inhibit human breast cancer growth

  2018cites this paper
• Biopharmaceutical characterization of porcine mesenchymal stromal cells as a model system for a human cell therapy product

  2018cites this paper
• Pyridoxal 5 '-phosphate dependent enzymes : classification and catalytic identities

  2017cites this paper
• Gene therapy in the treatment of human cancer

  2017cites this paper
• Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

  2017cites this paper
• The impact of γ-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use

  2017cites this paper
• Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.

  2017cites this paper
• University of Groningen Ovarian cancer gene therapy

  2017cites this paper
• Effects of a novel β–lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis

  2016cites this paper
• Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes

  2016cites this paper
• Ectopic Expression of Human Herpesvirus 1 Thymidine Kinase Induces Male Infertility

  2016cites this paper
• Spatiotemporal PFQNM visualization of the effect of suicide dendriplexes on dividing HeLa cells.

  2016cites this paper
• Gene Therapy of Malignant Glioma Hanna Stedt Gene Therapy of Malignant Glioma Alternative Strategies and Combination Therapies

  2015cites this paper
• Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

  2015cites this paper
• Improving Adenovirus Efficacy with p14 Fusion Associated Small Transmembrane Protein Expression for Cancer Treatment

  2015cites this paper
• Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.

  2014cites this paper
• Gene therapy for malignant glioma

  2014cites this paper
• Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice

  2014cites this paper
• Genetic cell ablation.

  2014cites this paper
• Stem Cell Sources and Their Homing to Tumors

  2013cites this paper
• Encapsulated stem cells for cancer therapy how this access benefits you. Your story matters

  2013cites this paper
• Encapsulated stem cells for cancer therapy

  2013cites this paper
• Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

  2013cites this paper
• Delivery, retention and engraftment of progenitor cells in cell therapy

  2013influential citation
• The design and optimization of RNA trans‐splicing molecules for skin cancer therapy

  2013cites this paper
• Viral and Non-Viral Gene Therapy for Glioblastoma: New Insights into theTreatment of Malignant Brain Tumors

  2013cites this paper
• Targeting Intercellular Communication in Cancer Gene Therapy

  2013cites this paper
• Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer

  2012cites this paper
• SUICIDE GENE THERAPY : COMPARING TWO DIFFERENT APPROACHES IN MELANOMA AND PROSTATE TUMOUR CELLS

  2012cites this paper
• The Functional Roles of Glial Cells in Health and Disease

  2012cites this paper
• 7 – Gene therapy for human brain tumors

  2012cites this paper
• PLP-Dependent Enzymes: a Potent Therapeutic Approach for Cancer and Cardiovascular Diseases

  2011cites this paper
• Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus.

  2011cites this paper
• Neural Stem Cell-based Gene Therapy for Brain Tumors

  2011cites this paper
• In Vivo Imaging of Intraprostatic-Specific Gene Transcription by PET

  2011cites this paper
• High therapeutic potential for systemic delivery of a liposome-conjugated herpes simplex virus.

  2011cites this paper
• [Gene therapy applications in gynecologic malignances management].

  2010cites this paper
• Therapeutic Efficacy of Human Hepatocyte Transplantation in a SCID/uPA Mouse Model with Inducible Liver Disease

  2010cites this paper
• Gap junctions sensitize cancer cells to proteasome inhibitor MG132‐induced apoptosis

  2010cites this paper
• Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells.

  2010cites this paper
• Selección positiva de células modificadas con genes suicidas como estrategia terapéutica contra el cáncer

  2010cites this paper
• Lentiviruses: Vectors for Cancer Gene Therapy

  2010cites this paper
• A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage–mediated, vascular-targeted suicide gene transfer

  2009cites this paper
• Adenovirus mediated herpes simplex virus-thymidine kinase/ganciclovir gene therapy for resectable malignant glioma.

  2009cites this paper
• Clinical trials for glioblastoma multiforme using adenoviral vectors.

  2009cites this paper
• Mouse models in skeletal physiology and osteoporosis: experiences and data on 14839 cases from the Hamburg Mouse Archives

  2009cites this paper
• NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors

  2009cites this paper
• The Development of Targeted Cancer Gene-Therapy Adenoviruses for High-Grade Glioma Treatment

  2009cites this paper
• Tumor cell apoptosis induces tumor‐specific immunity in a CC chemokine receptor 1‐ and 5‐dependent manner in mice

  2008cites this paper
• Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases

  2008cites this paper
• Use of Flp-mediated cassette exchange in the development of a CHO cell line stably producing erythropoietin.

  2008cites this paper
• Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound.

  2008cites this paper
• Interfering with cellular signaling pathways enhances sensitization to combined sodium butyrate and GCV treatment in EBV-positive tumor cells.

  2008cites this paper
• The Role of DNA Damage and Repair in Ganciclovir-mediated Cytotoxicity.

  2008cites this paper
• Expression et localisation de la connexine 43 dans le glioblastome : implication pour la thérapie génique

  2008cites this paper
• Conventional and gene therapy strategies for the treatment of brain tumors.

  2008cites this paper
• Neural stem cell-mediated enhanced gene therapy of malignant gliomas using a novel plant thymidine kinase

  2008cites this paper
• Quantifying a bystander response following microbeam irradiation using single-cell RT-PCR analyses.

  2007cites this paper
• Gene therapeutics: the future of brain tumor therapy?

  2006cites this paper
• A novel strategy to compensate the disadvantages of live vaccine using suicide-gene system and provide better antitumor immunity.

  2006cites this paper
• Cancer gene therapy: Combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect

  2006cites this paper
• Gene therapy for malignant mesothelioma: beyond the infant years

  2006cites this paper
• Consequences of chemoresistance for the herpes simplex virus thymidine kinase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model.

  2005cites this paper
• Gene therapy of mesothelioma

  2005cites this paper
• Ovarian cancer gene therapy strategies

  2005cites this paper
• Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells

  2005cites this paper
• Replacement and suicide gene therapy for targeted treatment of lung cancer.

  2005cites this paper
• Targeted gene therapy for ovarian cancer.

  2005cites this paper
• Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase

  2005cites this paper
• Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines.

  2005cites this paper
• Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.

  2004cites this paper
• Bystander-Mediated Regression of Murine Neuroblastoma via Retroviral Transfer of the HSV-TK Gene

  2004cites this paper
• Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells.

  2004cites this paper
• Gene Therapy for the Treatment of Cancer

  2004cites this paper
• Delivery of cytotoxic drugs from carrier cells to tumour cells by apoptosis

  2004cites this paper
• Successful lipofectin mediated transduction of a pIRES-fl-tk gene in human breast carcinoma: effective inducing the expansion as well as increasing the activity of dendritic cells.

  2004cites this paper
• Immune response to suicide gene therapy.

  2004cites this paper
• Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene

  2004cites this paper
• Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.

  2004cites this paper
• Biological Responses in Known Bystander Cells Relative to Known Microbeam-Irradiated Cells

  2004cites this paper
• Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.

  2004cites this paper
• Current strategies in cancer gene therapy.

  2004cites this paper
• Gene therapy for sarcoma utilizing adenoviral transfer of the beta-glucuronidase and bax genes and an anthracyline prodrug.

  2004cites this paper